• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Ingevity Corporation

    2/7/24 8:58:48 AM ET
    $NGVT
    Major Chemicals
    Industrials
    Get the next $NGVT alert in real time by email
    SC 13G 1 ingevitycorp13g_123123.htm

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. )*

    Ingevity Corp.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    45688C107

    (CUSIP Number)

    December 31, 2023

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    x  Rule 13d-1(b)
    ¨  Rule 13d-1(c)
    ¨  Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
     

     

             
    CUSIP No. 45688C107   13G   Page 2 of 4 Pages
             

     

             
    1.  

    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Victory Capital Management Inc.

    13-2700161

       
    2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    ¨
    (b)    ¨
       
    3.   SEC USE ONLY
     
       
    4.   CITIZENSHIP OR PLACE OF ORGANIZATION
     
    New York
       

     

             
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5.   SOLE VOTING POWER
     
    1839610
      6.   SHARED VOTING POWER
     
    0
      7.   SOLE DISPOSITIVE POWER
     
    1854554
      8.   SHARED DISPOSITIVE POWER
     
    0

     

             
    9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1854554
       
    10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ¨
       
    11.  

    PERCENT OF CLASS REPRSENTED BY AMOUNT IN ROW (9)

     

    5.12%

       
    12.   TYPE OF REPORTING PERSON (see instructions)

    IA
       
             
     
     

     

             
    CUSIP No. 45688C107   13G   Page 3 of 4 Pages
             

    Item 1.

      (a)

    Name of Issuer

    Ingevity Corp.
      (b)

    Address of Issuer’s Principal Executive Offices

    4920 O'Hear Avenue Suite 400 North Charleston, SC 29405

         

    Item 2.

      (a) Name of Persons Filing
      Victory Capital Management Inc.
         
      (b)

    Address of the Principal Office or, if none, residence
    4900 Tiedeman Rd. 4th Floor

    Brooklyn, OH 44144

         
      (c) Citizenship
      New York
         
      (d) Title of Class of Securities
      Common Stock
         
      (e) CUSIP Number
      45688C107
         
         

    Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
           
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
           
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(J).
     
     

    Item 4.  Ownership.

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

             
      (a)   Amount beneficially owned:  1,854,554
             
      (b)   Percent of class:  5.12%
             
      (c)   Number of shares as to which the person has:  
             
          (i) Sole power to vote or to direct the vote:  1,839,610
             
          (ii) Shared power to vote or to direct the vote:  0
             
          (iii) Sole power to dispose or to direct the disposition of: 1,854,554
             
          (iv) Shared power to dispose or to direct the disposition of:  0
               

     

    Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

    Item 5.  Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

     

    Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

    The clients of Victory Capital Management Inc., including investment companies registered under the Investment Company Act of 1940 and separately managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the class of securities reported herein of Ingevity Corp. No client has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5% of such class.

     

    Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

    Item 8.  Identification and Classification of Members of the Group.

     Not applicable.

    Item 9.  Notice of Dissolution of Group.

     Not applicable.

             

     

     
     

     

             
    CUSIP No. 45688C107   13G   Page 4 of 4 Pages
             

    Item 10.  Certification.

    (a)   The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):
             
          By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.  
             

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

    2/7/2024

    Date

     

    /s/ Barry Garrett

     

    Barry Garrett/Chief Compliance Officer

     

     

     

    Get the next $NGVT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NGVT

    DatePrice TargetRatingAnalyst
    2/26/2025$62.00 → $65.00Market Perform → Outperform
    BMO Capital Markets
    8/7/2024$58.00Market Perform → Market Outperform
    CJS Securities
    4/22/2024$52.00 → $62.00Hold → Buy
    Jefferies
    11/6/2023$49.00Market Outperform → Market Perform
    CJS Securities
    10/3/2023$62.00 → $53.00Buy → Hold
    Loop Capital
    8/7/2023$71.00 → $60.00Outperform → Market Perform
    BMO Capital Markets
    7/27/2023$64.00 → $75.00Hold → Buy
    Loop Capital
    5/5/2023$92.00 → $64.00Buy → Hold
    Loop Capital
    More analyst ratings

    $NGVT
    SEC Filings

    View All

    SEC Form 10-Q filed by Ingevity Corporation

    10-Q - Ingevity Corp (0001653477) (Filer)

    8/5/25 4:45:46 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Ingevity Corp (0001653477) (Filer)

    8/4/25 4:27:48 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Ingevity Corp (0001653477) (Filer)

    7/1/25 6:46:15 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ingevity reports second quarter 2025 financial results

    HIGHLIGHTS: Net sales of $365.1 million, down 7% compared to prior year, primarily due to lower sales in Performance Chemicals Net loss of $146.5 million and diluted loss per share of $4.02 included an Advanced Polymer Technologies pre-tax non-cash goodwill impairment charge of $183.8 million Adjusted earnings of $51.1 million were up 39% and diluted adjusted earnings per share of $1.39 was up 38% Adjusted EBITDA of $110.0 million increased 9% and adjusted EBITDA margin improved to 30.1% primarily due to the successful execution of repositioning actions in Performance Chemicals Operating cash flow of $79.0 million with free cash flow of $66.8 million Ingevity raises the lo

    8/4/25 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity named one of America's Best Mid-sized Companies by TIME

    Ingevity Corporation (NYSE:NGVT) today announced it has been named one of "America's Best Mid-Size Companies 2025" by TIME Magazine and Statista. This award recognizes 500 top-performing U.S. companies with revenues between $100 million and $10 billion that demonstrate strong performance amid a rapidly evolving economic landscape. "Ingevity is proud to receive this acknowledgement for our excellence in prioritizing people and purpose," said Dave Li, Ingevity president and CEO. "This recognition reflects our team's dedication to operating responsibly, supporting our communities and delivering long-term value for our stakeholders." Ingevity's ranking was based on a combination of direct a

    7/22/25 11:00:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces dates for second-quarter 2025 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2025 earnings after the stock market close on Monday, August 4, 2025. The company will host a live webcast on Tuesday, August 5, at 10:00 a.m. (Eastern) to discuss second-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 590026. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on August 5, 2

    7/22/25 9:00:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Finance & CAO Platt Phillip John covered exercise/tax liability with 1,444 shares, decreasing direct ownership by 5% to 28,243 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    8/13/25 4:25:16 PM ET
    $NGVT
    Major Chemicals
    Industrials

    SVP, Gen. Counsel & Secretary Fisher Ryan C. covered exercise/tax liability with 169 shares, decreasing direct ownership by 1% to 14,758 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    7/9/25 9:23:04 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Director Willis J Kevin was granted 620 shares, increasing direct ownership by 9% to 7,794 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    7/3/25 12:38:40 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ingevity upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously

    2/26/25 7:15:06 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by CJS Securities with a new price target

    CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00

    8/7/24 9:18:13 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by Jefferies with a new price target

    Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously

    4/22/24 7:39:26 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Leadership Updates

    Live Leadership Updates

    View All

    Ingevity announces departure of Performance Materials segment president, Ed Woodcock

    Ingevity Corporation (NYSE:NGVT) today announced Ed Woodcock, executive vice president and president, Performance Materials, departed the company effective July 1, 2025. Woodcock's departure follows a 37-year career with the company. "Ed Woodcock's leadership has been foundational to the successful growth of Ingevity's Performance Materials activated carbon business as the industry leader in automotive emissions capture," said Ingevity president and CEO, Dave Li. "During his extensive career with the company, Ed drove global expansion of the business, delivered consistently strong profitability and positioned the Performance Materials segment for growth in the hybrid and electric vehicle

    7/1/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders

    Board and Management Team Have Taken Significant and Decisive Action to Respond to External Market Challenges Key Transformational Changes Are Driving Strong Financial Results and Stock Price Outperformance Continued Execution of Proven Strategy Positions Ingevity to Unlock Significant Additional Stockholder Value Company Urges Stockholders to Vote "FOR" ONLY Ingevity's Highly Qualified Director Nominees on the WHITE Proxy Card Launches VoteIngevity.com Providing Additional information for Stockholders Ingevity Corporation (NYSE:NGVT) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its 2025 Annual Meet

    3/20/25 5:34:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces appointment of David H. Li as president and CEO

    Li brings 25-year+ record of driving successful corporate transformation, long-term growth and stockholder value creation at premier global specialty materials supplier Ingevity Corporation (NYSE:NGVT) today announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025, and that he is expected to join the board of directors following the 2025 Annual Meeting. Li succeeds Ingevity board member, Luis Fernandez-Moreno, who has been serving as interim president and CEO since October 2024. Fernandez-Moreno will remain on Ingevity's board. This press release features multimedia. View the full release here: https://www.businesswir

    3/10/25 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/12/24 3:54:24 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/4/24 11:52:25 AM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form SC 13D/A filed by Ingevity Corporation (Amendment)

    SC 13D/A - Ingevity Corp (0001653477) (Subject)

    2/28/24 5:30:32 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Financials

    Live finance-specific insights

    View All

    Ingevity reports second quarter 2025 financial results

    HIGHLIGHTS: Net sales of $365.1 million, down 7% compared to prior year, primarily due to lower sales in Performance Chemicals Net loss of $146.5 million and diluted loss per share of $4.02 included an Advanced Polymer Technologies pre-tax non-cash goodwill impairment charge of $183.8 million Adjusted earnings of $51.1 million were up 39% and diluted adjusted earnings per share of $1.39 was up 38% Adjusted EBITDA of $110.0 million increased 9% and adjusted EBITDA margin improved to 30.1% primarily due to the successful execution of repositioning actions in Performance Chemicals Operating cash flow of $79.0 million with free cash flow of $66.8 million Ingevity raises the lo

    8/4/25 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces dates for second-quarter 2025 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2025 earnings after the stock market close on Monday, August 4, 2025. The company will host a live webcast on Tuesday, August 5, at 10:00 a.m. (Eastern) to discuss second-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 590026. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on August 5, 2

    7/22/25 9:00:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity reports first quarter 2025 financial results

    HIGHLIGHTS: Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99 Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials Operating cash flow of $25.4 million with free cash

    5/5/25 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials